Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
24.01M | 18.76M | 11.94M | 7.71M | 6.65M | Gross Profit |
10.37M | 8.61M | 6.15M | 5.58M | 4.75M | EBIT |
79.00K | 231.00K | -18.00K | -1.25M | -1.69M | EBITDA |
1.40M | 1.34M | 960.00K | -196.00K | -473.60K | Net Income Common Stockholders |
697.00K | 390.00K | 97.00K | -1.09M | -4.58M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.22M | 1.17M | 902.00K | 2.10M | 2.35M | Total Assets |
14.49M | 13.86M | 11.29M | 11.09M | 13.30M | Total Debt |
383.00K | 386.00K | 690.00K | 665.00K | 863.00K | Net Debt |
-837.00K | -787.00K | -212.00K | -1.43M | -1.49M | Total Liabilities |
3.83M | 4.43M | 3.18M | 3.30M | 4.21M | Stockholders Equity |
10.66M | 9.43M | 8.11M | 7.79M | 9.09M |
Cash Flow | Free Cash Flow | |||
338.00K | 445.00K | -1.08M | -569.00K | -3.21M | Operating Cash Flow |
2.13M | 1.55M | -227.00K | 90.00K | -2.25M | Investing Cash Flow |
-1.80M | -1.10M | -852.00K | -338.00K | -3.98M | Financing Cash Flow |
-257.00K | -225.00K | -164.00K | -7.00K | 8.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £4.68B | 26.75 | 60.10% | 2.89% | 17.40% | 25.15% | |
72 Outperform | £18.12M | 25.25 | 6.54% | ― | 15.82% | 37.50% | |
66 Neutral | £59.44M | 4.63 | 9.85% | ― | -10.76% | ― | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% | |
49 Neutral | £108.52M | 41.57 | 2.25% | 3.43% | -11.17% | -85.43% |